NCT05426525View on ClinicalTrials.gov

Use of Empagliflozin to Treat Prediabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
PreDiabetesPrediabetic StateOverweight and Obesity
Interventions
DRUG

Empagliflozin

Participants will take 10mg empagliflozin per day for 2 weeks. Absent contraindications, dosing will be increased to 25 mg empagliflozin per day for the next 11 weeks.

DRUG

Multivitamin-Placebo

Participants will take 1 multivitamin per day for 13 weeks.

Trial Locations (1)

97331

Oregon State University, Corvallis

All Listed Sponsors
collaborator

Samaritan Health Services

OTHER

lead

Oregon State University

OTHER